Literature DB >> 15474572

Effect of stimulus localisation on motion-onset VEP.

J Kremlácek1, M Kuba, J Chlubnová, Z Kubová.   

Abstract

Reliable motion-onset visual evoked potentials (result of the dorsal stream activation) were recorded to motion stimuli with the temporal frequency of five cycles per seconds in 20 different locations with eccentricity up to 42 degrees to periphery of the visual field. Amplitudes and latencies of the positive-negative-positive (P1-N1-P2; 84-144-208 ms) complex were evaluated in occipital (OZ and two derivations 5 cm to the left and right from OZ) and central region (CZ) in 10 subjects. We observed: (1) Shortening of the N1 latency toward periphery of the visual field. (2) The N1 amplitude maximum and latency minimum moved from occipital into central region (CZ derivation) as stimulus moved from centre toward periphery of visual field. (3) The P1 and N1 peaks displayed significantly greater amplitudes and shorter latencies when the lower part of the visual field was stimulated. (4) The N1 peak changed lateralisation of its maximum amplitude in dependence on the eccentricity. Up to 17 degrees, it corresponds to striate projection of the "optic radiation" whilst more in periphery, there was paradoxical lateralisation of higher amplitude and shorter latency. The retinotopic dependence shows that the motion response includes position information and that the motion-onset VEPs are not generated solely in the higher extrastriate areas (MT or MST).

Entities:  

Mesh:

Year:  2004        PMID: 15474572     DOI: 10.1016/j.visres.2004.07.002

Source DB:  PubMed          Journal:  Vision Res        ISSN: 0042-6989            Impact factor:   1.886


  16 in total

1.  Visual evoked potentials to pattern, motion and cognitive stimuli in Alzheimer's disease.

Authors:  Z Kubová; J Kremlácek; M Valis; J Langrová; J Szanyi; F Vít; M Kuba
Journal:  Doc Ophthalmol       Date:  2010-06-04       Impact factor: 2.379

Review 2.  A primer on motion visual evoked potentials.

Authors:  Sven P Heinrich
Journal:  Doc Ophthalmol       Date:  2007-02-16       Impact factor: 2.379

3.  Within-session reproducibility of motion-onset VEPs: effect of adaptation/habituation or fatigue on N2 peak amplitude and latency.

Authors:  Jan Kremlácek; Miroslav Kuba; Zuzana Kubová; Jana Langrová; Frantisek Vít; Jana Szanyi
Journal:  Doc Ophthalmol       Date:  2007-05-31       Impact factor: 2.379

4.  Visual field asymmetries in visual evoked responses.

Authors:  Donald J Hagler
Journal:  J Vis       Date:  2014-12-19       Impact factor: 2.240

5.  Normal sensory and absent cognitive electrophysiological responses in functional visual loss following chemical eye burn.

Authors:  Nada Jiraskova; Miroslav Kuba; Jan Kremlacek; Pavel Rozsival
Journal:  Doc Ophthalmol       Date:  2011-06-07       Impact factor: 2.379

6.  Perception of structured optic flow and random visual motion in infants and adults: a high-density EEG study.

Authors:  Audrey L H van der Meer; Gjertrud Fallet; F R Ruud van der Weel
Journal:  Exp Brain Res       Date:  2007-12-18       Impact factor: 1.972

7.  The what and why of perceptual asymmetries in the visual domain.

Authors:  A K M Rezaul Karim; Haruyuki Kojima
Journal:  Adv Cogn Psychol       Date:  2010-12-15

8.  The functional role of the medial motion area V6.

Authors:  Sabrina Pitzalis; Patrizia Fattori; Claudio Galletti
Journal:  Front Behav Neurosci       Date:  2013-01-16       Impact factor: 3.558

9.  Unattended and attended visual change detection of motion as indexed by event-related potentials and its behavioral correlates.

Authors:  Nele Kuldkepp; Kairi Kreegipuu; Aire Raidvee; Risto Näätänen; Jüri Allik
Journal:  Front Hum Neurosci       Date:  2013-08-14       Impact factor: 3.169

10.  Vision before and after scharioth macular lens implantation in patients with AMD: an electrophysiological study.

Authors:  Jan Kremláček; Jana Nekolová; Markéta Středová; Jana Langrová; Jana Szanyi; Miroslav Kuba; Zuzana Kubová; František Vít; Petr Voda; Martina Veselá; Naďa Jirásková
Journal:  Doc Ophthalmol       Date:  2021-01-03       Impact factor: 2.379

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.